Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
49 studies found for:    Open Studies | "Pigmentation Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
Conditions: Surgical Wound;   Hypo-pigmented Skin
Intervention: Device: Momelan Technologies Epidermal Graft Harvesting System
2 Not yet recruiting Open-label Pilot Study of Abatacept for the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Abatacept
3 Recruiting Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
Condition: Vitiligo
Interventions: Drug: topical tacrolimus treatment;   Drug: topical pimecrolimus treatment;   Drug: local mometasone furoate treatment;   Drug: cold cream
4 Recruiting The Effect of Xolair ® (Omalizumab) in Mastocytosis Patients
Condition: Mastocytosis
Intervention: Drug: injections
5 Unknown  Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
Condition: Kidney Failure, Chronic
Intervention: Drug: vitamin C, intravenous injection
6 Unknown  Efficacy and Safety of ACH24 in the Treatment of Vitiligo
Condition: Vitiligo
Interventions: Drug: Group 01;   Drug: Group 02
7 Recruiting Efficacy and Safety of Biocellulose Sheet Containing Anti-hyperpigmentation Agent ("Biocellulose Mask", "Farhorm®") in Patients Receiving Laser Treatment
Conditions: Skin Pigmentation;   Skin Irritation
Intervention: Device: "Biocellulose Mask", Farhorm®"
8 Recruiting Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Conditions: Albinism;   Intestinal Disease;   Kidney Disease;   Myocardial Disease;   Pulmonary Fibrosis
Intervention:
9 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
10 Recruiting Imiquimod to Detect Residual Lesions and Prevent Recurrence of Lentigo Maligna
Condition: Lentigo Maligna
Intervention: Drug: Imiquimod
11 Unknown  A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in the Treatment of Patients With Smouldering Systemic, Indolent Systemic or Cutaneous Mastocytosis With Handicap
Conditions: Smouldering Systemic Mastocytosis;   Indolent Systemic Mastocytosis;   Cutaneous Mastocytosis With Handicap;   Mastocytosis
Interventions: Drug: masitinib (AB1010);   Drug: placebo
12 Recruiting The Cancer of the Pancreas Screening-5 CAPS5)Study
Conditions: Pancreas Cancer;   Peutz-Jeghers Syndrome;   Gene Mutation;   Germline Mutation Carrier;   Lynch Syndrome
Intervention: Drug: Human synthetic secretin
13 Recruiting Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
Conditions: Xeroderma Pigmentosum;   Melanoma;   Squamous Cell Carcinoma;   Basal Cell Carcinoma;   Skin Cancer
Intervention:
14 Not yet recruiting SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia)
Conditions: Myelofibrosis;   Chronic Myelomonocytic Leukemia;   Advanced Systemic Mastocytosis;   Advanced Symptomatic Primary Eosinophilic Disorder
Intervention: Drug: SL-401
15 Recruiting Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Triamcinolone Acetonide
16 Unknown  Xeroderma Pigmentosum Patient Experiences
Condition: Xeroderma Pigmentosum
Intervention: Other: Survey Study
17 Unknown  NB-UVB and PUVA Vitiligo Study
Condition: Vitiligo
Interventions: Other: Phototherapy;   Other: Phototherapy and Photochemotherapy
18 Recruiting Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia
Conditions: Aggressive Systemic Mastocytosis;   Mast Cell Leukemia;   Systemic Mastocytosis
Interventions: Drug: brentuximab vedotin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Other: questionnaire administration
19 Unknown  Long-term Follow-up in Patients Affected With Acrofacial Vitiligo
Condition: Vitiligo
Intervention:
20 Recruiting Nitisinone for Type 1B Oculocutaneous Albinism
Conditions: Albinism;   Vision Loss
Intervention: Drug: Nitisinone (NTBC)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years